Jordina Llao - Publications

Influence of vedolizumab on extraintestinal manifestations in inflammatory bowel disease: a nationwide multicenter study of the GETECCU ENEIDA Registry.

Journal: Journal of Crohn's & colitis

Published: March 26, 2026

Addition of pulse corticosteroids to oral prednisone in moderately active ulcerative colitis: a randomized, multicentre, open-label study by GETECCU.

Journal: Journal of Crohn's & colitis

Published: November 19, 2025

Performance of existing predictive scores of response in patients with moderately active ulcerative colitis treated with oral corticosteroids.

Journal: Revista espanola de enfermedades digestivas

Published: November 17, 2025

Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry.

Journal: United European gastroenterology journal

Published: October 23, 2025

Esophageal, gastric and duodenal Crohn's disease in the biologic era: Results from a retrospective observational nationwide study of GETECCU.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: October 11, 2025

Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.

Journal: The American journal of gastroenterology

Published: June 07, 2024

Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.

Journal: Pharmaceutics

Published: March 25, 2024

Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project.

Journal: Postgraduate medical journal

Published: February 10, 2024

Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn's disease patients.

Journal: The pharmacogenomics journal

Published: September 04, 2023

Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry.

Journal: Journal of Crohn's & colitis

Published: July 31, 2023

Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.

Journal: Therapeutic advances in gastroenterology

Published: June 19, 2023

Endoscopic treatment (endoscopic balloon dilation/self-expandable metal stent) vs surgical resection for the treatment of de novo stenosis in Crohn's disease (ENDOCIR study): an open-label, multicentre, randomized trial.

Journal: Trials

Published: December 19, 2022